Abstract
Various cutaneous manifestations have been reported after receiving the COVID-19 vaccine of different types. The commonest reactions were delayed large local reactions, local injection site reactions, urticaria, and morbilliform eruptions following mRNA vaccines. There are very few reports of erythema multiforme (EM) and pityriasis rosea(PR) following Covid vaccines. Erythema multiforme (EM) is one of the commonest reaction following viral infections, drugs and vaccines. Here we are reporting a case of atypical erythema multiforme like pityriasis rosea manifestation following Covishield Covid vaccine second dose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IP Indian Journal of Clinical and Experimental Dermatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
